William Hait - Oct 24, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Title: Chief External Innovation and Medical Safety Officer
Signature
Raavi Deol, as attorney-in-fact for William Hait
Stock symbol
JNJ
Transactions as of
Oct 24, 2022
Transactions value $
-$1,216,620
Form type
4
Date filed
10/26/2022, 04:51 PM
Previous filing
Apr 25, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $1.36M +15K +18.69% $90.44 95.2K Oct 24, 2022 Direct
transaction JNJ Common Stock Sale -$204K -1.19K -1.25% $171.55 94K Oct 24, 2022 Direct
transaction JNJ Common Stock Sale -$2.37M -13.8K -14.69% $171.55 80.2K Oct 24, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -15K -50.51% $0.00 14.7K Oct 24, 2022 Common Stock 15K $90.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $171.52 to $171.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Title: Chief External Innovation and Medical Safety Officer